<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02180399</url>
  </required_header>
  <id_info>
    <org_study_id>6031</org_study_id>
    <nct_id>NCT02180399</nct_id>
  </id_info>
  <brief_title>Serial Measurement of Capillary Blood Lactate in the Management of Sepsis</brief_title>
  <acronym>SepsisMI</acronym>
  <official_title>Role of the Serial Measurement of Capillary Blood Lactate in the Management of Sepsis Outside the Intensive Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determination of capillary lactate by using &quot;point-of-care&quot; technique is accessible, fast and
      allows to quantify the circulatory and metabolic dysfunction caused by sepsis. Compared to
      conventional assay techniques in arterial blood, capillary assay technique may have an
      increased susceptibility to metabolic alterations induced by sepsis in its initial stages.
      This increased sensitivity is not necessarily relevant in the management of the most serious
      patients for whom the diagnosis is obvious, but it could be very useful in patients for whom
      a diagnosis of severe sepsis or shock have not yet been adopted, particularly to help better
      identify patients who would require intensive management and avoid the installation of these
      serious disorders.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2014</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measurement of capillary blood lactate</measure>
    <time_frame>72 hours after inclusion</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sepsis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients over age 18 with an acute systemic inflammatory response syndrome array of
        presumed infectious not yet been treated.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Installation without any plausible explanation of at least one of the following
             clinical criteria:

               -  Chills, fever, mottling, respiratory rate&gt; 20/min; Sat02 &lt; 90% or &gt; 94% with more
                  than 4l O2, heart rate &gt; 90/min,systolic blood pressure &lt; 100 mmHg or 40 mmHg
                  lower compared with normal values, Glasgow coma score &lt; 14. or: .a combination of
                  two (or more) of clinical and laboratory criteria for sepsis.

          -  Signed informed consent form

        Exclusion Criteria:

          -  Need in its current treatment of aerosol administration of beta agonists at a
             frequency greater than one per 8 hours;

          -  Targeted therapeutic measures have already stated for more than 60 minutes;

          -  Diagnosis other than Sepsis;

          -  Malignant neoplasm or other progressive disease and expected survival was less than 3
             months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel ANDRES, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospitals of Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emmanuel ANDRES, MD, PhD</last_name>
    <phone>33 3 88 11 50 66</phone>
    <email>Emmanuel.ANDRES@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adrian PURCAREA, MD</last_name>
    <phone>33 3 88 11 50 66</phone>
    <email>adrianpetru.purcarea@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SERVICE DE MED. INTERNE - DIABETE ET MALADIES METABOLIQUES, 1-place de l'Hôpital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrian PURCAREA, MD</last_name>
      <phone>(33) 03.88.11.67.20</phone>
      <email>adrianpetru.purcarea@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Interne - Clinique Médicale B</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel ANDRES, MD, PhD</last_name>
      <phone>33 3 88 11 50 66</phone>
      <email>emmanuel.andres@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Adrian PURCAREA, MD</last_name>
      <phone>33 3 88 11 50 66</phone>
      <email>adrianpetru.purcarea@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Emmanuel ANDRES, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrian PURCAREA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2014</study_first_submitted>
  <study_first_submitted_qc>June 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2014</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Capillary blood lactate</keyword>
  <keyword>Serial measurement of capillary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

